BRPI0923346A2 - Proteinas em super-helice antiparalela de cadeia simples - Google Patents

Proteinas em super-helice antiparalela de cadeia simples

Info

Publication number
BRPI0923346A2
BRPI0923346A2 BRPI0923346A BRPI0923346A BRPI0923346A2 BR PI0923346 A2 BRPI0923346 A2 BR PI0923346A2 BR PI0923346 A BRPI0923346 A BR PI0923346A BR PI0923346 A BRPI0923346 A BR PI0923346A BR PI0923346 A2 BRPI0923346 A2 BR PI0923346A2
Authority
BR
Brazil
Prior art keywords
proteins
superhelic
hrs3
hrs2
hrs1
Prior art date
Application number
BRPI0923346A
Other languages
English (en)
Inventor
Loverix Stefan
Desmet Johan
Lasters Ignace
Original Assignee
Complix Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Complix Nv filed Critical Complix Nv
Publication of BRPI0923346A2 publication Critical patent/BRPI0923346A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROTEÍNAS EM SUPER-HÉLICE ANTIPARALELA DE CADEIA SIMPLES. A presente invenção se refere a proteínas de cadeia simples de fórmula HRS1-L1-HRS2-L2-HRS3, em que HRS1, HRS2 E HRS3 são seqüências de hepta repetições e L1 e L2 são seqüências de ligante (linker) estruturalmente flexíveis, e em que HRS1, HRS2 e HRS3 formam uma estrutura em super-hélice de alfa-hélice antiparalela de fita tripla termodinamicamente estável em solução aquosa. A invenção também se refere a variantes de seqüência de aminoácidos, condições e métodos para obter tais proteínas e variantes, e usos dos mesmo, especialmente seu uso como armações e como produtos terapêuticos.
BRPI0923346A 2008-12-08 2009-12-08 Proteinas em super-helice antiparalela de cadeia simples BRPI0923346A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12064208P 2008-12-08 2008-12-08
PCT/EP2009/066640 WO2010066740A1 (en) 2008-12-08 2009-12-08 Single-chain antiparallel coiled coil proteins

Publications (1)

Publication Number Publication Date
BRPI0923346A2 true BRPI0923346A2 (pt) 2017-07-11

Family

ID=41571709

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923346A BRPI0923346A2 (pt) 2008-12-08 2009-12-08 Proteinas em super-helice antiparalela de cadeia simples

Country Status (10)

Country Link
US (2) US20110294983A1 (pt)
EP (1) EP2367840B1 (pt)
JP (1) JP2012510806A (pt)
CN (1) CN102245623A (pt)
AU (1) AU2009326075B2 (pt)
BR (1) BRPI0923346A2 (pt)
CA (1) CA2749558C (pt)
DK (1) DK2367840T3 (pt)
ES (1) ES2547121T3 (pt)
WO (1) WO2010066740A1 (pt)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE538129T1 (de) * 2007-09-07 2012-01-15 Complix N V Nicht natürliches proteinöses gerüst aus drei nicht kovalent assoziierten peptiden
GB2471692A (en) * 2009-07-08 2011-01-12 Complix Nv HIV gp41-binding single-chain coiled-coil peptide comprising heptad repeats
CN102939004B (zh) 2010-04-06 2015-09-23 阿格罗塞文公司 农用化学品的特异性输送
GB201014715D0 (en) 2010-09-06 2010-10-20 Vib Vzw Nanobodies stabilizing functional conformational states of GPCRS
PT2609119T (pt) 2010-08-26 2017-11-10 Agrosavfe N V Proteínas de ligação ao antigénio de polissacáridos quitinosos
WO2012025602A1 (en) 2010-08-26 2012-03-01 Vib Vzw Insect binding antibodies
GB201018602D0 (en) 2010-11-04 2010-12-22 Vib Vzw MMP8 inactivating antigen binding proteins
EP2656079A2 (en) 2010-12-20 2013-10-30 Universiteit Gent Crystal structure of flt3 ligand-receptor complex
WO2012093013A1 (en) 2011-01-06 2012-07-12 Complix Nv Alphabodies specifically binding to class-i viral fusion proteins and methods for producing the same
EP2661446B1 (en) * 2011-01-06 2015-09-30 Complix SA Alphabody libraries and methods for producing the same
AU2012204846B2 (en) * 2011-01-06 2016-09-08 Complix Nv Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptors
WO2012092971A1 (en) 2011-01-06 2012-07-12 Complix Nv Alphabodies specifically binding to viral proteins and methods for producing the same
GB201104469D0 (en) 2011-03-17 2011-04-27 Univ Gent Control of phagocytosis
EP2723764B1 (en) 2011-06-21 2017-12-27 Vib Vzw Binding domains directed against gpcr: g protein complexes and uses derived thereof
EP2763529A1 (en) 2011-10-06 2014-08-13 Agrosavfe N.V. Manufacturing of specifically targeting microcapsules
JP2015504064A (ja) * 2012-01-06 2015-02-05 コンプリクス エン ヴェー 細胞内標的分子に対する結合剤
EP2617732A1 (en) 2012-01-19 2013-07-24 Vib Vzw Tools and methods for expression of membrane proteins
WO2013107791A1 (en) 2012-01-20 2013-07-25 Vib Vzw Targeted mutant alpha-helical bundle cytokines
DK2909233T3 (en) 2012-10-22 2017-02-20 Complix Nv Polypeptides that can internalize cellularly
EP2909235B1 (en) 2012-10-22 2017-03-29 Complix NV Polypeptides specifically binding to il-23
CA2899274A1 (en) 2013-01-29 2014-08-07 The University Court Of The University Of Glasgow Methods and means for increasing stress tolerance and biomass in plants
PL2951201T3 (pl) 2013-01-30 2018-03-30 Vib Vzw Nowe polipeptydy chimeryczne do celów badań przesiewowych i odkrywania leków
ES2745772T3 (es) 2013-02-05 2020-03-03 Vib Vzw Agentes de unión al receptor muscarínico de la acetilcolina y usos de los mismos
TR201819577T4 (tr) 2013-04-29 2019-01-21 Agrosavfe N V Sfingolipitleri bağlayan antikorlar içeren agrokimyasal bileşimler.
CA2917105C (en) 2013-07-01 2023-09-26 Bayer Cropscience Nv Methods and means for modulating flowering time in monocot plants
WO2015007536A2 (en) 2013-07-18 2015-01-22 Vib Vzw Fusokines involving cytokines with strongly reduced receptor binding affinities
KR102268688B1 (ko) 2013-07-19 2021-06-24 브이아이비 브이지더블유 표적화된 변형된 tnf 패밀리 구성원
JP6475712B2 (ja) 2013-07-19 2019-02-27 ヴィブ ブイゼットダブリュー サイトカインアンタゴニストの標的化
US9932409B2 (en) 2013-07-19 2018-04-03 Vib Vzw Targeted modified IL-1 family members
WO2015097289A1 (en) 2013-12-24 2015-07-02 Vib Vzw Secretion and functional display of chimeric polypeptides
GB201400997D0 (en) 2014-01-21 2014-03-05 Vib Vzw Targeting of interleukin-1 and -18 in treatment of septic shock
US10233241B2 (en) 2014-01-30 2019-03-19 Vib Vzw Opioid receptor binding agents and uses thereof
US10479832B2 (en) 2014-03-31 2019-11-19 Universiteit Gent Method of treating bone disease
US10641779B2 (en) 2014-07-22 2020-05-05 Vib Vzw Methods to select for agents that stabilize protein complexes
WO2016050512A1 (en) 2014-10-03 2016-04-07 Bayer Cropscience Nv Methods and means for increasing stress tolerance and biomass in plants
BR112017009330A2 (pt) 2014-11-05 2017-12-19 Agrosavfe N V planta transgênica que compreende um polinucleotídeo que codifica um domínio variável de anticorpo de cadeia pesada
WO2016129656A1 (ja) * 2015-02-12 2016-08-18 国立大学法人岩手大学 哺乳動物細胞に対する外来遺伝子の導入効率の向上剤
US11702477B2 (en) 2015-11-06 2023-07-18 Orionis Biosciences BV Bi-functional chimeric proteins and uses thereof
WO2017096236A1 (en) 2015-12-02 2017-06-08 Fred Hutchinson Cancer Research Center Circular tandem repeat proteins
CN108883180B (zh) 2016-02-05 2023-07-07 奥里尼斯生物科学私人有限公司 Clec9a结合剂及其用途
US11661455B2 (en) 2016-02-05 2023-05-30 Orionis Biosciences BV Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
US11248057B2 (en) 2016-03-07 2022-02-15 Vib Vzw CD20 binding single domain antibodies
JP2019519468A (ja) 2016-04-01 2019-07-11 ユニバーシティ オブ ワシントンＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｗａｓｈｉｎｇｔｏｎ モジュラー水素結合ネットワーク介在特異性を有するホモオリゴマーを形成することができるポリペプチドおよびその設計
EP3455245A2 (en) 2016-05-13 2019-03-20 Orionis Biosciences NV Therapeutic targeting of non-cellular structures
CA3023883A1 (en) 2016-05-13 2017-11-16 Orionis Biosciences Nv Targeted mutant interferon-beta and uses thereof
AU2017340387A1 (en) * 2016-10-04 2019-05-02 University Of Florida Research Foundation, Inc. Targeted effector proteins and uses thereof
ES2917000T3 (es) 2016-10-24 2022-07-06 Orionis Biosciences BV Interferón-gamma mutante diana y usos del mismo
MX2019009255A (es) 2017-02-06 2019-11-05 Orionis Biosciences Nv Proteínas quiméricas dirigidas y sus usos.
US10906985B2 (en) 2017-02-06 2021-02-02 Orionis Biosciences, Inc. Targeted engineered interferon and uses thereof
WO2018146074A1 (en) 2017-02-07 2018-08-16 Vib Vzw Immune-cell targeted bispecific chimeric proteins and uses thereof
DK3601367T3 (da) 2017-03-30 2025-01-13 Univ Queensland Kimære molekyler og anvendelse deraf
EP3415010A1 (en) 2017-06-13 2018-12-19 Agrosavfe Nv Insect-controlling polypeptides and methods
CA3069930A1 (en) 2017-08-09 2019-02-14 Orionis Biosciences Inc. Cd8 binding agents
SG11202001063QA (en) 2017-08-09 2020-03-30 Orionis Biosciences Inc Clec9a binding agents and use thereof
CA3069994A1 (en) 2017-08-09 2019-02-14 Orionis Biosciences Inc. Pd-1 and pd-l1 binding agents
US11407797B2 (en) 2017-10-11 2022-08-09 University Of Florida Research Foundation, Incorporated Modified gal-1 proteins and uses thereof
EP3833391A4 (en) 2018-08-08 2022-08-10 Orionis Biosciences, Inc. CHIMERIC PROTEINS TARGETED AT SIRP1alpha AND THEIR USES
CA3118892A1 (en) 2018-11-08 2020-05-14 Orionis Biosciences, Inc. Modulation of dendritic cell lineages
WO2020176900A1 (en) 2019-02-28 2020-09-03 University Of Florida Research Foundation, Incorporated Galectin-1/ galectin-3 chimeras and multivalent proteins
CA3133643A1 (en) 2019-03-28 2020-10-01 Orionis Biosciences, Inc. Therapeutic interferon alpha 1 proteins
KR20220012227A (ko) 2019-03-28 2022-02-03 오리오니스 바이오사이언시즈 인코포레이티드 Clec9a-기반 키메라 단백질 복합체
US20220276244A1 (en) 2019-04-29 2022-09-01 Confo Therapeutics N.V. Chimeric proteins and methods to screen for compounds and ligands binding to gpcrs
US12544426B2 (en) 2019-06-19 2026-02-10 Orionis Biosciences, Inc. Combination therapy with CD13-targeted chimeric proteins or chimeric protein complexes
WO2021140205A1 (en) 2020-01-10 2021-07-15 Confo Therapeutics N.V. Methods for generating antibodies and antibody fragments and libraries comprising same
MX2022012376A (es) 2020-03-31 2023-02-15 Biotalys NV Polipeptidos antifungicos.
WO2022087458A1 (en) 2020-10-23 2022-04-28 Asher Biotherapeutics, Inc. Fusions with cd8 antigen binding molecules for modulating immune cell function
CN112382336B (zh) * 2020-12-01 2023-09-01 北京晶泰科技有限公司 一种小蛋白骨架设计方法及其应用
US20240124539A1 (en) * 2020-12-28 2024-04-18 New York University Crosslinked helix dimer mimics of sos and methods of using same
WO2023057601A1 (en) 2021-10-06 2023-04-13 Biotalys NV Anti-fungal polypeptides
WO2023203127A1 (en) 2022-04-20 2023-10-26 Vib Vzw Alphabody-based degrader molecules
CN120112556A (zh) 2022-08-18 2025-06-06 英美偌科有限公司 多结构域结合分子
CA3264964A1 (en) 2022-08-18 2024-02-22 Immunocore Limited MULTI-DOMAIN BONDING MOLECULES
CN118290566B (zh) * 2022-12-22 2025-01-03 南京诺唯赞生物科技股份有限公司 一类新的重组胶原蛋白及其制备方法和用途
WO2024145551A1 (en) 2022-12-29 2024-07-04 Biotalys NV Agrochemical compositions
GB202306345D0 (en) 2023-04-28 2023-06-14 Immunocore Ltd Binding molecules
US12378306B2 (en) 2023-12-22 2025-08-05 Biotalys NV Anti-fungal VHH antibodies
WO2026008785A1 (en) 2024-07-03 2026-01-08 Biotalys NV Agrochemical compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077103A2 (en) * 2004-02-12 2005-08-25 Regents Of The University Of Colorado Compositions and methods for modification and prevention of sars coronavirus infectivity
ATE538129T1 (de) 2007-09-07 2012-01-15 Complix N V Nicht natürliches proteinöses gerüst aus drei nicht kovalent assoziierten peptiden
EP2161278B1 (en) * 2008-09-08 2012-05-23 Complix N.V. Single-chain coiled coil scaffold

Also Published As

Publication number Publication date
CA2749558C (en) 2019-01-15
EP2367840B1 (en) 2015-08-12
AU2009326075B2 (en) 2014-06-05
JP2012510806A (ja) 2012-05-17
DK2367840T3 (en) 2015-10-12
CA2749558A1 (en) 2010-06-17
AU2009326075A1 (en) 2011-06-30
ES2547121T3 (es) 2015-10-01
US20160039867A1 (en) 2016-02-11
US20110294983A1 (en) 2011-12-01
CN102245623A (zh) 2011-11-16
WO2010066740A1 (en) 2010-06-17
EP2367840A1 (en) 2011-09-28

Similar Documents

Publication Publication Date Title
BRPI0923346A2 (pt) Proteinas em super-helice antiparalela de cadeia simples
CY1121225T1 (el) Συμπυκνωμενες iμιδαζολυλιμιδαζολες ως αντιiκες ενωσεις
CY1121452T1 (el) Παραγωγα πουρινης για τη θεραπευτικη αντιμετωπιση ιικων λοιμωξεων
CY1122691T1 (el) Πρωτεϊνες δεσμευσης αλβουμινης ορου
MX2009010610A (es) Dominio de enlace especifico de especies cruzadas.
PA8815201A1 (es) Compuestos heterociclicos
PA8811501A1 (es) Nuevos derivados de insulina con perfil tiempo/acción extremadamente retardado
CY1119056T1 (el) Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna
ES2678696T3 (es) Proteínas de fusión dirigidas/inmunomoduladoras y métodos de preparación de las mismas
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
PH12012502272A1 (en) Biological materials related to her3
MX362981B (es) Moleculas artificiales de acido nucleico para la expresion mejorada de proteina o peptido.
MX2014006396A (es) Vacunas contra el virus de la influenza y sus usos.
BR112016002753A2 (pt) anticorpos contra o inibidor-1 de ativador de plasminogênio (pai-1) e usos dos mesmos
BR112017015833A2 (pt) compostos anti-senescência e usos dos mesmos
CO6470802A2 (es) Péptido auxiliar del antígeno del cáncer
UY30338A1 (es) Acidos carboxilicos sustituidos con fenilaminobenzoxazol, procedimientos para su preparacion y su uso como productos farmacéuticos.
CY1115945T1 (el) Παραγωγα πυραζολοκινολινονης, η παρασκευη τους και η θεραπευτικη τους χρηση
ECSP11011327A (es) Derivados de aminotetralina, composiciones farmacéuticas que los contienen, y sus usos en terapia
BR112012015740A2 (pt) anticorpos de anti-flt3 e metodos de uso dos mesmos
CR20110619A (es) Produccion recombinante de peptidos
UA115043C2 (uk) Амідні похідні n-карбамідзаміщених амінокислот як модулятори формілпептидного рецептора 1 (fprl-1)
CR11511A (es) Nuevos derivados de insulina con perfil tiempo/accion extremadamente retardado
CR20130202A (es) Polipéptidos que se enlazan a cxcr2
AR092076A1 (es) Proteinas homodimericas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements